Eisai And Merck Announce FDA Approval Of LENVIMA Capsules For Treatment Of Unresectable HCC
Eisai Inc. and Merck, known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved the kinase inhibitor LENVIMA …
Read More...
Read More...